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Abstract 
 
Objective 
Delayed gadolinium enhanced MRI of cartilage (dGEMRIC) facilitates non-invasive 
evaluation of the glycosaminoglycan content in articular cartilage. The primary aim of 
this study was to show that the dGEMRIC technique is able to monitor cartilage 
repair following regenerative cartilage treatment. 
 
Design 
Thirty-one patients with a focal cartilage lesion underwent a dGEMRIC scan prior to 
cartilage repair surgery and at 3 and 12 months follow-up. At similar time points 
clinical improvement was monitored using the KOOS and Lysholm questionnaires. 
Per MRI scan several regions-of-interest (ROI) were defined for different locations in 
the joint. The dGEMRIC index (T1gd) was calculated for each ROI. RMANOVA 
analysis was used to evaluate improvement in clinical scores and MRI T1gd over 
time. Also regression analysis was performed to show the influence of local repair on 
cartilage quality at distant locations in the knee.  
 
Results 
Clinical scores and the dGEMRIC T1gd per ROI showed a statistically significant 
improvement (p<0.01), from baseline, at 12 months follow-up. Also, improvement 
from baseline in T1gd of the ROI defining the treated cartilage defect showed a direct 
relationship (p<0.007) to the improvement of the T1gd of ROI at other locations in the 
joint. 
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Conclusions 
The dGEMRIC MRI protocol is a useful method to evaluate cartilage repair. In 
addition, local cartilage repair influenced the cartilage quality at other location in the 
joint. These findings validate the use of dGEMRIC for noninvasive evaluation of the 
effects of cartilage regeneration. 
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Introduction 
 
Focal articular cartilage lesions in the knee are frequently treated by microfracture or 
autologous chondrocyte implantation.1 Treatment failure, is often related to 
inadequate tissue regeneration.2 Also, good structural repair at short-term follow-up 
showed to result in good clinical outcome at later time points.3,4 
In clinical trials, the success of cartilage regeneration is usually determined by 
histological evaluation of regenerated tissue obtained from an additional cartilage 
biopsy from the newly formed tissue. The disadvantages of a cartilage biopsy, and 
the main reasons for which it has not been introduced as a standard protocol in 
clinical practice, is the invasive nature of the procedure and the fact that it only 
provides local information. Therefore, a non-invasive method to determine tissue 
organization and to assess the distribution of relevant articular cartilage matrix 
proteins would be of great value in the evaluation of tissue regeneration. 
The non-invasive MR imaging technique called dGEMRIC (delayed Gadolinium 
Enhanced MRI of Cartilage) can be used to assess the concentration of GAGs in the 
extracellular cartilage matrix.5 This technique is based upon the negatively charged 
ions of the T1-shortening contrast agent gadolinium diethylene triamine pentaacetic 
acid (Gd-DTPA2-, Magnevist) that distribute inversely proportional to the 
concentration of the also negatively charged GAGs in articular cartilage. The Gd-
DTPA2- concentration per voxel is described by means of the dGEMRIC index (T1gd) 
which is calculated from the 5 different inversion times using a curve fitting method. 
In areas with low GAG the calculated T1gd will be low, and vice versa. A good 
correlation was found between the biochemically determined GAG contents and the 
related T1gd times in ex vivo studies.5,6 In addition, it was shown that the dGEMRIC 
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technique can be used to evaluate the quality of articular cartilage after 
osteochondral autologous transplantation, high tibial osteotomy and matrix-assisted 
ACI. 7-11  
In addition to the availability of techniques evaluating the outcome of defect 
treatment, it is becoming increasingly evident that its success is directly dependent 
on patient characteristics.12 Factors such as age and gender of the patient and size, 
age and location of the focal lesion were shown to influence clinical outcome after 
regenerative cartilage therapy.12 However, it is not known to what extent these 
characteristics also affect the biological repair response.  
Therefore, the primary aim of this study was to show that the dGEMRIC technique is 
able to monitor cartilage repair following regenerative cartilage treatment. We also 
evaluated to what extent local cartilage repair influences the cartilage quality in the 
whole knee. Also, specific patient and defect characteristics were evaluated for their 
influence on cartilage repair. 
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Material and Methods 
 
 
General study outline and patient population 
 
This study was conducted with approval of the institutional ethical committee under 
protocol number 08-022/E. Patients with a substantial decrease in sports 
participation or limitations in activities of daily living combined with a strong suspicion 
of a focal (osteo)chondral lesion on MRI were planned for arthroscopy and indicated 
for treatment, with either microfracture, MACI, ChondroCelect or Chondron 
treatment13. These patients were eligible for inclusion in this study. If patients signed 
consent a preoperative dGMERIC scan was obtained. Patients with general 
contraindications for MRI scanning, a known allergic reaction to gadolinium-
containing contrast agents or with a history of kidney pathology were considered not 
eligible for inclusion. If, during arthroscopy, the treating physician found that the 
lesion or other cartilage surfaces were not suitable to receive any of the 
abovementioned treatments, the included patient was excluded from the study. From 
April 2009 – March 2010 a total of 40 patients diagnosed with a symptomatic 
(osteo)chondral focal articular cartilage lesion met the inclusion criteria and were 
willing to participate in this study. The study procedures and risks were explained 
and, after a minimum of 14 days, informed consent was obtained by a physician not 
involved in the diagnostic and therapeutic process (JEJB). One patient was excluded 
when receiving her first study MRI because of MRI artefacts possibly resulting from 
previous anterior cruciate ligament reconstruction. In addition, 7 patients were 
excluded during surgery for two reasons; they either showed generalized cartilage 
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degeneration (n=2) or the characteristics of the lesion were not suitable for 
abovementioned treatments (n=5). One patient was lost to follow-up at 12 months. 
The baseline characteristics of the 31 patients who were included and completed the 
study are provided in Table 1.  All included patients were evaluated before surgery 
(on average 33 ± 18 days, range 1-78 days) as well as 3 and 12 months after surgery 
by a dGEMRIC examination and clinical questionnaires. 
 
 
Cartilage evaluation by dGEMRIC 
 
All dGEMRIC scans were performed on a 1.5-T clinical MRI scanner (Achieva, 
Philips Healthcare, Best, The Netherlands) using a dedicated 8-element sense knee 
coil as a receiver (Philips Healthcare, Best, The Netherlands). Scanning took place 
90 minutes after intravenous injection of Magnevist (Gd-DTPA2-, Bayer, Germany) at 
a dose of 0.2 mmol/kg body weight. After survey scans, a transient field echo (TFE) 
pulse sequence was used for dGEMRIC with 5 different inversion delay times (50, 
150, 350, 650 and 1650 ms), as previously described by McKenzie et al.14 A total of 
36 partitions were obtained with a 256x232 in plane acquisition matrix resulting in a 
voxel size of 0.625 x 0.625 x 3 mm3, using an echo time of 4.3 ms, a repetition time 
of 10 ms and a flip angle of 20 degrees. The average T1Gd per ROI was calculated 
after voxelwise fitting of the dGEMRIC signal equation as a function of inversion time 
using the Levenberg-Marquardt non-linear least-squares method implemented in in-
house developed software. On the sagittal images obtained in the dGEMRIC scan 
with an inversion delay time of 350 ms a total of 6 different ROIs (Figure 1) were 
drawn using a smartboard with projection on an interactive screen. The defect ROI 
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was the region of the treated defect. The cartilage segmentation in the defect ROI 
was separated from the adjacent (non) defect cartilage using the length, width and 
size of the defect (obtained from surgery reports). Based on the voxel size of the 
obtained dGEMRIC scans we calculated the number of slices and width of the defect 
on the sagittal images for segmentation. In the articular cartilage directly opposing 
and articulating with the treated defect the articulating ROI was drawn. The three joint 
compartments, patellofemoral, lateral and medial tibiofemoral, were, depending on 
the site of the cartilage defect, separately identified as the treated ROI and two other 
ROIs. Finally a whole knee ROI was created that consisted of a segmentation of all 
the articular surfaces in the knee. All segmentations were performed by one person 
(JEJB) and consensus with an experienced knee specialized orthopaedic surgeon 
was obtained in case of any doubts. Baseline ROIs were used and plotted on the 
follow-up scans at 3 and 12 months to guarantee similar sized ROIs over time. For a 
set of 15 scans all ROIs were, with an interval of 1 month, repeated by the same 
observer to evaluate the internal consistency and reliability of the segmentation 
process, 
 
Evaluation of clinical outcome 
 
The clinical treatment outcome was assessed using two different questionnaires both 
validated for the evaluation of the clinical status of patients treated for an articular 
cartilage lesion.15,16  
The Knee injury and Osteoarthritis Outcome Score (KOOS) was designed to 
evaluate the short- and long-term follow-up of treatment of knee injury and knee 
osteoarthritis. Recently this questionnaire was validated to measure the clinical 
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condition in patients after regenerative cartilage surgery.15 The KOOS consists of 5 
subdomains; symptoms, pain, activities of daily living, function in sport and recreation 
and knee-related quality-of-life. The KOOS score per subdomain (score 0-100) was 
calculated using the free available scoring sheet on the KOOS website 
(http://www.koos.nu/). 
The Lysholm questionnaire was initially designed to evaluate the functional 
disabilities resulting from ligamentous injury. Recently, this questionnaire has also 
been validated to asses articular cartilage damage.16 The questionnaire consists of 8 
domains (pain, instability, locking, swelling, limping, walking stairs, squatting and 
keeping support) and translates to a score between 0 and 100 (normal knee 
function).  
 
Statistical analysis 
 
All statistical analysis was performed using SPSS statistical software version 15.0 
(Chicago, USA). Internal consistency of the segmentation process was performed by 
the Crohnbach’s alpha and the reliability using the intraclass correlation coefficient 
(ICC).  
Repeated measures ANOVA: 
Absolute improvement from baseline at 3 and 12 months follow-up for (subdomains 
of) the clinical questionnaires and ROIs was calculated (by extracting the baseline 
values from the 3 and 12 month values) and tested using a repeated-measures 
ANOVA with a repeated model fit. All variables showed a normal distribution 
(Kolmogorov-Smirnov p>0.05) equality of variance (Levene’s test p>0.05) and met 
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the assumption of sphericity (Mauchly’s test p>0.32) and could therefore validly be 
included in the repeated-measures model. 
To correct for a false positive interpretation of statistical significance among the 
multiple tests that were performed to show the, possible, improvement over time of 
one variable a Bonferroni correction was performed following the repeated-measures 
model. Improvement over time is, for all variables, presented as average ± standard 
deviation. 
Conditions for regression analysis:  
A regression analysis was performed to evaluate possible relations between our 
outcome variables. Before valid inclusion into the regression model, all variables 
were subjected to a normality test by the Kolmogorov-Smirnov coefficient, a test for 
intervariable correlation and multicollinearity (Pearson correlation coefficient and the 
variance inflation factor) and an assessment for autocorrelation (correlation within a 
single variable) with the Durbin-Watson coefficient. Also, in multiple regression 
analysis, the unstandardized residuals were evaluated for the absence of 
intercorrelation and scatterplots were created to test normal residual distribution and 
homoscedasticity. A Kolmogorov-Smirnov coefficient with p>0.05 indicates normal 
distribution while a variance inflation factor close to 0 or >5 was considered indicative 
of multicollinearity. A Durbin-Watson coefficient close to 0 is related to strong 
negative autocorrelation, whereas a Durbin-Watson close to 4 suggests strong 
positive autocorrelation. 
For each regression analysis, the B-coefficient, standard error of the B-coefficient, 
the 95% confidence interval (95%CI), the R2 and p-value of the model were obtained. 
The B-coefficient explains the relation between the predictor and dependent variable 
where an increase of 1 unit of the predictor results in an increase of the dependent 
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variable by the value of B. This relation is statistically significant if the p<0.05 and 
causality counts for the percentage expressed by the R2. 
Linear regression analysis: 
Linear regression analysis was performed to evaluate whether local regeneration 
(expressed by the 12 months improvement in measured T1gd from baseline in the 
defect ROI) influences other joint compartments. For this, a single linear regression 
model was applied with the absolute improvement of measured T1gd in the defect 
ROI as a predictor variable and the absolute improvement of measured T1gd of the 
other ROIs (articulating, treated, other 1, other 2 and whole) as dependent variables. 
Multiple regression analysis: 
Multiple linear regression with backward elimination was performed to test what 
patient characteristic were related to improvement in defect T1gd after 12 months. 
For all statistical analysis a p-value of p<0.05 was considered statistically significant. 
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Results 
 
 
dGEMRIC and clinical scores; improvement from baseline 
 
The segmentation process was valid with a Crohnbach’s alpha of 0.86 and an ICC of 
0.91. 
At baseline, the T1gd ranged from 365-484ms for the different ROIs (defect 365±46, 
articulating 484±125, treated 421±48, other1 422±60, other2 448±68, whole 432±54). 
The KOOS scores at baseline were lowest for the sports and quality of life 
subdomains (pain 59±19, activity of daily living 65±20, symptoms 62±18, sports 
27±22, quality of life 24±15). The baseline Lysholm score was 48±21 points. 
Except for the articulating ROI, the T1gd indices at 3 months after surgery were 
slightly, but statistically non-significantly, decreased compared to the baseline values 
(Table 2, defect 362±54, articulating 481±171, treated 407±68, other1 411±61, other2 
419±55, whole 415±58). After 12 months follow-up, the T1gd of the defect and the 
articulating ROI showed the largest, statistically significant (p<0.01) improvement 
from baseline (defect 468±91, articulating 622±241), which was also clearly visible on 
the dGEMRIC images (Figure 2). In addition, the T1gd of the other ROIs (treated 
481±91, other1 503±85, other2 680±63, whole 484±67) also showed a clear, and 
statistically significant (p<0.01), improvement from baseline. 
At 3 months after surgery, the clinical scores did not show a statistically significant 
change from baseline (Table 2). However, at 12 months follow-up all but 3 patients 
showed clearly improved clinical scores. Improvement from baseline was noted on 
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the Lysholm, the KOOS subdomains and the KOOS overall scores (p<0.01) (Table 
2). 
 
Regression analysis; effect of defect treatment on distant cartilage quality 
 
All variables in the regression analysis had a normal distribution (normality tests 
p>0.358) and no multicollinearity or autocorrelation were found (variance inflation 
factor, 1.000; Durbin-Watson range, 2.199–2.510). Also scatterplots of model 
residuals showed normal residual distribution and homoscedasticity of residuals. 
The increase in T1gd after 12 months at the defect ROI was significantly related to 
the T1gd increase of the other ROIs in the joint (Table 3). The B-values ranged from 
0.787-0.567 indicating that for each millisecond increase in T1gd at the treated defect 
after 12 months, the T1gd of the cartilage at another location in the joint increased 
with 0.787-0.567 ms. 
Multiple regression analysis showed that the patient characteristics (gender, patient 
age, defect age and defect size,) did not influence (p>0.070) the improvement in 
T1gd after 12 months for the defect ROI. However, defect size and patient age were 
shown to influence the improvement in T1gd of the whole ROI at 12 months after 
surgery. A defect size >3 cm2 was related to 58±24 less increase (p=0.024) in T1gd 
of the joint as a whole after 12 months compared to defects <3 cm2 and in patients 
<30 years old a 152±47 stronger increase (p=0.005) in the T1gd was found 
compared to those >30 years old at 12 months after surgery. 
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Discussion: 
 
This study evaluated the feasibility of noninvasive monitoring by dGEMRIC of defect 
repair and general tissue integrity of cartilage in the joint after cartilage repair 
surgery. The dGEMRIC scanning technique was useful in detecting local cartilage 
repair in a focal defect one year after treatment, which was accompanied by clearly 
improved clinical scores. In addition, local improvement of T1gd was directly related 
to the improvement of cartilage quality in other joint compartments. Also, patient age 
and defect size influenced the treatment response of the articular cartilage in the 
whole knee. 
The International Cartilage Research Society has recently published several 
guidelines for histological and MRI based evaluation of cartilage repair studies.17,18 
Histological evaluation of newly formed cartilage provides information on the 
structural organization and can help to understand the biological success of tissue 
regeneration.17 Disadvantages of histological evaluation are the time consuming 
processing and the small volume of tissue that can be analyzed. Moreover, the 
invasive nature of the necessary biopsy makes longitudinal follow-up less desirable 
from an ethical point of view. Contrast-enhanced MRI scanning protocols, such as 
dGEMRIC, are able to represent tissue structure and can be readily applied in a 
longitudinal follow-up. Moreover, with MRI the whole joint can be assessed instead of 
only small tissue volumes after biopsy. 
Overall the dGEMRIC technique is reliable as repeated measurements show a good 
reproducibility.19-21 Also the coefficient of variation in the bulk T1gd for certain 
cartilage ROIs was 5%, ranging from 4.2%-5.5% for femur and tibia cartilage 
respectively.19 However, recent reports question the robustness of the physical 
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properties at which the dGEMRIC technique is based on. The measurement of bulk 
T1gd values from articular cartilage 1.5 hour after scanning is based on the 
assumption of a steady state concentration gradient at that time.14 However, recently 
it was shown that the depth-wise concentration gradient of Gd-DTPA2- is continuously 
changing which could make bulk ROI measurements less reliable.22 In addition, the 
diffusion time of Gd-DTPA2- seemed slower than previously assumed and the 
distribution of Gd-DTPA2- is also influenced by the collagen content of the articular 
cartilage.23 These observations should be taken into account when dGEMRIC data is 
being evaluated and one should be cautious to directly relate measured T1gd to 
tissue GAGs. Abovementioned issues are a limitation of the dGEMRIC technique and 
manuscripts that directly relate dGEMRIC findings to tissue GAG. In addition this 
study could have been strengthened when also other quantitative MRI techniques, 
such as T2 mapping or proton density sequences, were added to the analysis. In 
addition, such scanning sequences are more reliable in the assessment of a focal 
lesion and therefore will lead to a more precise segmentation of the cartilage in the 
focal defect area. This could prevent from an erroneous baseline T1gd values of the 
defect ROI resulting from a segmentation that includes limited amounts of the -
gadolinium containing- synovial fluid in the defect.  Also longer follow-up would have 
provided more information on the use of non-invasive evaluation tools, such as 
dGEMRIC, for the evaluation of articular cartilage following cartilage repair. 
To our knowledge one study also compared the T1gd values measured in a focal 
cartilage lesion to those 1 year after matrix-associated ACI.9 However, the main 
outcome parameter of that study was to evaluate the zonal distribution of GAGs, 
using dGEMRIC, in normal and repair tissue. Therefore, the study may have been 
underpowered (n=15) to show statistically significant T1gd improvement between the 
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preoperative and postoperative scans. Therefore, this is the first study to show that a 
dGEMRIC scanning protocol can be used to longitudinally show improvement in 
T1gd, as a possible representation of tissue GAG concentration, following cartilage 
repair. 
Several other groups already used dGEMRIC to evaluate articular cartilage after ACI, 
but focussed on differences between repair and native tissue, the zonal organization 
of the newly formed tissue or only performed post-surgery dGEMRIC without 
baseline measurements.7,9,11,24 Considering the large variation in T1gd times 
between patients, it is difficult to define a consensus T1gd that represents acceptable 
or good quality cartilage after regeneration. Therefore, patient specific baseline 
measurements are essential when cartilage quality following regenerative surgery is 
a relevant outcome in a longitudinal study. 
During the different phases of cartilage regeneration the organization of matrix 
constituents and water content change continuously.18 These factors influence the T1 
relaxation time of the newly formed tissue and most likely lead to differences of the 
measured T1 relaxation times in repair tissue compared to the reference healthy or 
degenerated cartilage.18 This should be taken into account when cartilage is being 
evaluated with the dGEMRIC technique. A direct comparison, using only post-
contrast imaging, between repair tissue and other locations in the joint could, 
therefore, introduce erroneous interpretation of the data and does not represent the 
true GAG content in articular cartilage.18 The delta relaxation rate (∆R1 = 1/T1 
precontrast – 1 / T1(Gd)) corrects for the differences in precontrast T1 and is 
preferred when different locations in the joint are being evaluated and compared in a 
cross-sectional study design.18 However, per location in the joint (either repair or 
healthy reference tissue) the correlation between the T1gd and ∆R1 is high and 
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separate interpretation of both outcome variables lead to similar conclusions.25 The 
absence of pre-contrast imaging, in this study, combined with a longitudinal 
evaluation at predefined locations does, for abovementioned reason, not influence 
data interpretation nor change the final conclusions. In addition, patient comfort will 
decrease when also a precontrast MRI scan was performed as scanning time would 
be twice as long. 
The clinical benefit following ACI and microfracturing is influenced by specific 
characteristics of the defect or patient.4,12,26-28 Also, in specific cases one technique 
may perform better than the other one does.4,12,27,29 In this study, the size of the 
defect and age of the patient showed a direct relation to the overall improvement in 
T1gd of the articular cartilage in the knee, at 12 months after surgery. This implies 
that specific biological characteristics of the defect and patient could play a role in the 
intrinsic repair capacity of the articular cartilage following surgery. The articular 
cartilage in the knee showed less improvement following cartilage surgery when a 
large defect (> 3 cm2) had been present. Whether the size of the defect is positively 
correlated to the severity of disturbance in joint homeostasis remains to be seen, 
however, the presence of an articular cartilage defect has been shown to induce joint 
cartilage degeneration.30 It has also been shown that larger defects, if left untreated, 
are related to an increased cartilage volume loss.31 Age influenced the improvement 
in T1gd following cartilage surgery in this study. Younger patients could be more 
sensitive for a regenerative response due to the senescence of cells and tissues 
related to the effects of aging.32 
Based on macroscopic and biochemical evaluation, the treatment of an articular 
cartilage defect has been related to a decrease in degenerative characteristics at 
other joint locations.30 In this study we showed, using regression analysis, that defect 
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treatment is related to the improvement of the T1gd at other locations in the joint 
which could imply improved cartilage quality. These findings underline the 
importance of the concept of joint homeostasis and the role for early detection and 
intervention. The presence of an articular defect should be regarded as indicative of 
a joint disease rather than a local problem. Timely treatment has been shown to 
improve clinical outcome, i.e. timely restoration of the joint homeostasis improves the 
regenerative response of the whole joint.4,12 Using dGEMRIC, such changes can be 
monitored thereby providing a reliable imaging tool for the evaluation of cartilage 
quality in the whole joint following cartilage repair. 
In conclusion, this study demonstrates that the dGEMRIC technique can be used to 
longitudinally measure changes in T1gd following cartilage repair surgery. Also, using 
dGEMRIC we showed that patient age and defect size influence the improvement in 
T1gd following cartilage surgery and that local repair influences the T1gd at distant 
locations in the joint. Taken together, these findings illustrate the value of dGEMRIC 
for the evaluation of the effects of cartilage repair and clearly indicate a role for early 
detection and intervention. 
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Figure legends 
 
 
Figure 1 
 
Title:  
Regions-Of-Interest. 
 
 
Legend:  
Sagittal MRI slices of the scan with 350ms inversion delay time showing example ROI 
segmentations as a color overlay. The color bar represents the calculated T1gd in 
milliseconds, where a high T1gd (1000 ms) is depicted as blue and a low T1gd (nearly 0 ms) 
as red. 
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Figure 2 
 
Title:  
dGEMRIC at baseline and 12 months follow-up. 
 
 
Legend:  
The blue pixels represent a high T1gd (1000 ms) while a low T1gd of 0 is labeled as red. At 
the preoperative situation a clear change in signal (from yellow to red) is visible at the site of 
the lesion when compared to the rest of the knee. At 12 months after surgery the overall 
signal in the knee is improved (more blue-green) with a clear signal improvement at the 
treated defect site. 
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Tables and table legends 
 
 
Table 1: 
Title: Baseline characteristics. 
 
Legend: *defect age from Chondron treatment patients is missing. 
 
 
 
 Patients 
(n=31) 
Gender  
Male n(%) 23 (74%) 
Female n(%) 8 (26%) 
Age mean±SD 36 ± 11 
<30 jr n(%) 12 (39%) 
>30 jr n(%) 19 (61%) 
Type of treatment  
MACI/CCI n(%) 12 (39%) 
MF n(%) 12 (39%) 
Chondron n(%) 7 (22%) 
Defect age* mean(months) ± SD 24 ± 17 
<2 y n(%) 12 (50%) 
>2 y n(%) 12 (50%) 
Defect size mean(cm2) ± SD 4 ± 2 
<3 cm2 12 (39%) 
>3 cm2 19 (61%) 
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Table 2:  
 
Title:  
Clinical outcome evaluation. 
 
Legend:  
Improvement from baseline (mean ± SD and (95%CI)) after 3 and 12 months 
(calculated by extracting the baseline values from the 3 and 12 month values) for 
both the clinical questionnaires and dGEMRIC ROIs. *p<0.01. 
 
 
 Baseline – 3 months Baseline – 12 months 
KOOS questionnaire   
Pain 12±4 (5 – 20)* 21±4 (13 – 29)* 
Symptoms 4±4   (-4 – 12) 15±4 (7 – 23)* 
Activity 6±4   (-1 – 14) 20±4 (13 – 27)* 
Sports -1±4  (-10 – 7) 29±5 (19 – 38)* 
QoL 5±3   (-1 – 11) 20±4 (13 – 28)* 
Overall KOOS 6±3   (0 – 13) 20±3 (14 – 27)* 
Lysholm 9±4   (1 – 17) 28±3 (21 – 35)* 
   
   
ROIs   
Defect -4±11   (-26 – 18) 103±13 (76 – 130)* 
Articulating 20±28  (-36 – 76) 158±46 (65 – 252)* 
Treated -19±10 (-39 – 2) 49±18   (12 – 86)* 
Other1 -11±10 (-30 – 9) 78±16   (44 – 111)* 
Other2 -16±10 (-38 – 5) 44±14   (15 – 72)* 
Whole -10±11 (-32 – 12) 51±15   (13 – 74)* 
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Table 3: 
 
Title:  
Defect treatment relates to overall cartilage improvement. 
 
Legend:  
Linear regression analysis using the increase in T1gd from baseline to 12 months at 
the defect ROI as a predictor for the increase in T1gd from baseline to 12 months at 
other joint locations/ROIs. The B-value represents the increase in the dependent 
variable when the increase in the predictor is 1. For example, when the T1gd at the 
defect ROI improves with 1 ms in 12 months’ time the T1gd of the treated joint 
compartment  (Treated ROI) improves with 0.787 explaining an influence of local 
regeneration on cartilage quality in locations in the joint.  
 
Dependent 
variable 
B p-value 95%CI 
lower 
95%CI 
upper 
Treated T0T12 0.787 0.001 0.364 1.210 
Other1 T0T12 0.651 0.002 0.253 1.049 
Other2 T0T12 0.567 0.002 0.233 0.901 
Whole 0.689 0.001 0.354 1.023 
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